Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 10/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | RBBP5 | Q15291 | 3/20 | 0.41 |
| ▸ | ASH2L | Q9UBL3 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4373425 | 0.77 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1DRD3KDM4EHSD17B10 | |
| SCHEMBL27789247 | 0.72 | KDM4E (0.53) | ALDH1A1KDM4EHSD17B10KMT2AMEN1 | |
| SCHEMBL9113476 | 0.71 | KDM4E (0.58) | WDR5ALDH1A1L3MBTL1KDM4EHSD17B10 | |
| SCHEMBL8556904 | 0.70 | KCNH2 (0.71) | ALDH1A1DRD3KDM4EHSD17B10KMT2A | |
| SCHEMBL195077 | 0.69 | KDM4E (0.46) | ALDH1A1KDM4EHSD17B10KMT2AMEN1 | |
| SCHEMBL6646448 | 0.69 | NPC1 (0.47) | ALDH1A1L3MBTL1DRD3KDM4EHSD17B10 | |
| SCHEMBL27372178 | 0.69 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1KDM4EHSD17B10KMT2A | |
| SCHEMBL3436293 | 0.69 | ALDH1A1 (0.49) | ALDH1A1L3MBTL1DRD3KDM4EKMT2A | |
| SCHEMBL30947749 | 0.69 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1DRD3KDM4EHSD17B10 | |
| SCHEMBL32691671 | 0.69 | TSHR (0.51) | ALDH1A1DRD3KDM4EHSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368634-A1 | PHENYL AMIDE COMPOUNDS AND METHODS OF USE | SCHRÖDINGER, INC. (US) | 2025-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368634-A1 | PHENYL AMIDE COMPOUNDS AND METHODS OF USE | AADAC, DBI, ASNS | WDR5 3786/4885ALDH1A1 2189/4885L3MBTL1 3847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.